atomoxetine hydrochloride has been researched along with Erectile Dysfunction in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Allen, AJ; Escobar, R; Kryzhanovskaya, LA; Lane, JR; Lipsius, S; Tanaka, Y; Trzepacz, PT; Upadhyaya, H | 1 |
| Adler, LA; Michelson, D; Milton, DR; Moore, RJ; Spencer, TJ | 1 |
2 trial(s) available for atomoxetine hydrochloride and Erectile Dysfunction
| Article | Year |
|---|---|
Time-to-onset and -resolution of adverse events before/after atomoxetine discontinuation in adult patients with ADHD.
Topics: Adrenergic Uptake Inhibitors; Adult; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Blood Pressure; Cardiovascular Diseases; Dose-Response Relationship, Drug; Double-Blind Method; Drug-Related Side Effects and Adverse Reactions; Erectile Dysfunction; Female; Heart Rate; Humans; Male; Time Factors; Treatment Outcome; Withholding Treatment | 2015 |
Long-term, open-label study of the safety and efficacy of atomoxetine in adults with attention-deficit/hyperactivity disorder: an interim analysis.
Topics: Adult; Age Factors; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Blood Pressure; Body Weight; Erectile Dysfunction; Female; Headache; Heart Rate; Humans; Longitudinal Studies; Male; Patient Dropouts; Placebos; Propylamines; Psychiatric Status Rating Scales; Treatment Outcome; Xerostomia | 2005 |